Stifel Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

$85.8 Billion
Q1 2024

A detailed history of Stifel Financial Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 44,909 shares of REGN stock, worth $47.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

44,909

Previous 41,679 7.75%

Holding current value

$47.2 Million

Previous $36.6 Million 18.08%

% of portfolio

0.05%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $2.92 Million - $3.21 Million	3,230 Added 7.75%	44,909 $43.2 Million
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $8.25 Million - $9.39 Million	10,649 Added 34.32%	41,679 $36.6 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $2.34 Million - $2.86 Million	3,385 Added 12.24%	31,030 $25.5 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $3.21 Million - $3.8 Million	4,579 Added 19.85%	27,645 $19.9 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $701,585 - $852,606	-1,031 Reduced 4.28%	23,066 $19 Million

Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $716,478 - $777,885	-1,015 Reduced 4.04%	24,097 $17.4 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $9.27 Million - $11.7 Million	-16,142 Reduced 39.13%	25,112 $17.3 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $1.91 Million - $2.57 Million	-3,475 Reduced 7.77%	41,254 $24.4 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $818,885 - $961,039	1,376 Added 3.17%	44,729 $31.2 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $957,068 - $1.18 Million	-1,761 Reduced 3.9%	43,353 $27.4 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $471,278 - $559,068	821 Added 1.85%	45,114 $27.3 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $7.81 Million - $9.22 Million	16,509 Added 59.42%	44,293 $24.7 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $818,856 - $1 Million	-1,833 Reduced 6.19%	27,784 $13.1 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $4.97 Million - $6.32 Million	-10,398 Reduced 25.99%	29,617 $14.3 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $1.13 Million - $1.36 Million	2,072 Added 5.46%	40,015 $22.4 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $9.38 Million - $12.2 Million	19,021 Added 100.52%	37,943 $23.7 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $3.84 Million - $5.65 Million	11,420 Added 152.23%	18,922 $9.19 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $7.94 Million - $9.25 Million	-29,044 Reduced 79.47%	7,502 $2.08 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $2.18 Million - $3.02 Million	-7,291 Reduced 16.63%	36,546 $11.4 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $2.51 Million - $2.96 Million	-6,740 Reduced 13.33%	43,837 $18 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $244,812 - $293,816	-729 Reduced 1.42%	50,577 $18.8 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $2.1 Million - $2.45 Million	5,992 Added 13.22%	51,306 $20.8 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $506,588 - $614,082	-1,780 Reduced 3.78%	45,314 $15.6 Million
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $10.9 Million - $13.5 Million	-34,400 Reduced 42.21%	47,094 $16.2 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $2.07 Million - $2.71 Million	-5,765 Reduced 6.61%	81,494 $30.8 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $37.6 Million - $44 Million	87,259	87,259 $0

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History